These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 15178305)

  • 1. Kinetics of hydrolysis of 4-methoxy-2-[2-hydroxy-3(4-phenyl-1-piperazinyl)]propyl-2,3-dihydro-6-methyl-1,3-dioxo-1H-pyrrolo[3,4-c]pyridine in aqueous solutions.
    Muszalska I
    Farmaco; 2004 Jun; 59(6):437-42. PubMed ID: 15178305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of pH and temperature on the degradation kinetics of 4-methoxy-2-[3-(4-phenyl-1-piperazinyl)]propyl-2,3-dihydro-6-methyl-1,3-dioxo-1H-pyrrolo[3,4-c] pyridine in aqueous solutions.
    Muszalska I; Wituła K
    Acta Pol Pharm; 2005; 62(2):83-8. PubMed ID: 16161346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of new analgesic active compound, pyrrolo-[3,4-c]pyridine derivative, in aqueous solutions.
    Muszalska I; Wojtyniak E
    Acta Pol Pharm; 2007; 64(4):319-25. PubMed ID: 18536157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A validated spectrophotometric and liquid chromatography method for determination and purity evaluation of 4-methoxy-2-[2-hydroxy-3(4-phenyl-1-piperazinyl)]propyl-2,3-dihydro-6-methyl-1,3-dioxo-1H-pyrrolo[3,4-c]pyridine.
    Muszalska I; Sadowska H; Szkatula D
    Farmaco; 2003 Jul; 58(7):513-9. PubMed ID: 12818690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of ertapenem in aqueous solutions.
    Zajac M; Cielecka-Piontek J; Jelińska A
    J Pharm Biomed Anal; 2007 Jan; 43(2):445-9. PubMed ID: 16914282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of hydrolysis of diltiazem hydrochloride in aqueous solutions.
    Muszalska I; Jamszoł L; Grześkowiak D
    Acta Pol Pharm; 2003; 60(3):163-8. PubMed ID: 14556482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPLC and TLC methodology for determination or purity evaluation of 4-methoxy-2-(3(4-phenyl-1-piperazinyl))propyl-2,3-dihydro-6-methyl-1,3-dioxo-1H-pyrrolo[3,4-c]pyridine.
    Muszalska I; Sladowska H; Sabiniarz A
    Acta Pol Pharm; 2005; 62(1):3-10. PubMed ID: 16022487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of hydrolysis of ceftazidime in aqueous solutions.
    Siwek J; Zajac M
    Acta Pol Pharm; 1995; 52(1):21-30. PubMed ID: 8984847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The stability of N-[2-(4-o-fluorophenylpiperazin-1-yl)ethyl]-2,5-dimethyl-1 -phenylpyrrole-3,4-dicarboximide in aqueous-organic solutions.
    Zajac M; Sobczak A; Malinka W; Redzicka A
    Acta Pol Pharm; 2010; 67(1):27-33. PubMed ID: 20210076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of ricobendazole in aqueous solutions.
    Wu Z; Tucker IG; Razzak M; Medlicott NJ
    J Pharm Biomed Anal; 2009 Jul; 49(5):1282-6. PubMed ID: 19342190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mechanistic and kinetic study of the beta-lactone hydrolysis of Salinosporamide A (NPI-0052), a novel proteasome inhibitor.
    Denora N; Potts BC; Stella VJ
    J Pharm Sci; 2007 Aug; 96(8):2037-47. PubMed ID: 17554770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The stability of oxymetazoline hydrochloride in aqueous solution.
    Stanisz B
    Acta Pol Pharm; 2002; 59(1):19-23. PubMed ID: 12026107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics and mechanism of the base-catalyzed rearrangement and hydrolysis of ezetimibe.
    Baťová J; Imramovský A; HájÍček J; Hejtmánková L; Hanusek J
    J Pharm Sci; 2014 Aug; 103(8):2240-7. PubMed ID: 24985565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of drug decomposition. Part 74. Kinetics of degradation of minocycline in aqueous solution.
    Pawełczyk E; Matlak B
    Pol J Pharmacol Pharm; 1982; 34(5-6):409-21. PubMed ID: 7187051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of drug decomposition. Part 67. Kinetics of degradation of dicloxacillin in aqueous solution.
    Pawełczyk E; Zajac M; Knitter B
    Pol J Pharmacol Pharm; 1981; 33(2):241-9. PubMed ID: 7312724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Degradation kinetics and mechanism of aminocephalosporins in aqueous solution: cefadroxil.
    Tsuji A; Nakashima E; Deguchi Y; Nishide K; Shimizu T; Horiuchi S; Ishikawa K; Yamana T
    J Pharm Sci; 1981 Oct; 70(10):1120-8. PubMed ID: 7299645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acid-base catalysis of N-[(morpholine)methylene]daunorubicin.
    Krause A; Jelińska A; Cielecka-Piontek J; Klawitter M; Zalewski P; Oszczapowicz I; Wąsowska M
    Drug Dev Ind Pharm; 2012 Aug; 38(8):1024-8. PubMed ID: 22124459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Degradation of berenil (diminazene aceturate) in acidic aqueous solution.
    Campbell M; Prankerd RJ; Davie AS; Charman WN
    J Pharm Pharmacol; 2004 Oct; 56(10):1327-32. PubMed ID: 15482649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cefuroxime hydrolysis kinetics and stability predictions in aqueous solution.
    Wang D; Notari RE
    J Pharm Sci; 1994 Apr; 83(4):577-81. PubMed ID: 8046618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of microcalorimetry and HPLC for the determination of degradation kinetics and thermodynamic parameters of Perindopril Erbumine in aqueous solutions.
    Simoncic Z; Roskar R; Gartner A; Kogej K; Kmetec V
    Int J Pharm; 2008 May; 356(1-2):200-5. PubMed ID: 18304767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.